Decision Diagnostics Conveys Opportunities and Potential

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Decision Diagnostics Conveys Opportunities and Potential Following Landmark Circuit Court Ruling Against Diabetes Testing Division of Johnson & Johnson

LOS ANGELES, CA--(Marketwired - Feb 9, 2016) - Decision Diagnostics Corp. ( OTC PINK : DECN ), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for GenStrip™ 50 and the GenUltimate™ glucose test strip, both designed to work with the market leading Johnson & Johnson's ("J&J") LifeScan OneTouch Ultra family of glucose testing meters, and the in-development GenSure™ glucose test strip targeted to the developing world markets, today relays a summary of the arguably illegitimate J&J/Lifescan lawsuit impact on DECN business activity, its current status and future expectations.

Corporate annual revenue generation approximated $15+ million from 2009-2012 from existing business activities, prior to the comprehensive 2012-2013 Medicare reimbursement reductions for at-home testing supplies. In 2012 the company assumed total program management of the Genstrip blood glucose test strip; including all regulatory activity directed towards FDA 510k market clearance. Concurrent to this transition, and prior to regulatory approval and Genstrip product introduction, J&J/Lifescan commenced its campaign of litigation, threats and intimidation to prevent the introduction of Genstrip to the diabetic patient population. They collectively filed patent infringement and trademark infringement lawsuits.

The FDA 510k market clearance in November, 2012, activated an intensive product launch and initiated an order wave that deluged manufacturing and overwhelmed capacity. Agreements were quickly executed with mass merchandisers, drug chains and grocery retailers. However, internal expectations for meteoric product growth and rapid revenue escalation were abruptly interrupted by lower court judges, persuaded by J&J/Lifescan assertions of false health risks and their own financial impairment, to enter two preliminary injunctions preventing the continued sale of Genstrip. Prior to the reversal of those injunctions by a rational Federal Circuit Court of Appeals panel, J&J/Lifescan expanded its scorched earth strategy through a communication campaign targeting all existing and prospective Genstrip customers. Each of these accounts received notifications, replete with distortions, suspect legal opinions and an explicit threat to employ the full financial power of the $75 billion corporate giant to sue any commercial Genstrip purchaser for patent infringement. This totally disingenuous, yet highly successful, campaign effectively neutralized the company's marketing plans for the Genstrip product through all second and third party sellers.

Keith Berman, Principal Executive of Decision Diagnostics commented, "We entered 2013 poised to capture a considerable share of the J&J/Lifescan $2+ billion test strip market. Although expecting J&J/Lifescan to make every effort to protect their market monopoly, we did not anticipate the breath of faithless tactics that they would employ to remove our looming threat to their cash cow franchise. Our only option was to repel their attacks and to pursue vindication through unconditional legal victory. We had been counseled that J&J/Lifescan frequently filed baseless lawsuits characterized by unfounded accusations, delaying tactics and often supported by incapable or fraudulent expert witnesses; forcing smaller undercapitalized competitors to capitulate under the weight of staggering legal defense costs. "

The company and its Pharma Tech Solutions subsidiary won, and won unconditionally. As announced, that ruling initiated a company legal claim and the aggressive pursuit of a court mandated J&J/Lifescan $12.7 million bond posted in the event that the imposed injunction was reversed or proven to be invalid. Additional legal pursuit against J&J/Lifescan will be activated for the extensive damages their improper behavior and anti-trust activities have inflicted on the company.

The multiple and final legal victories now reopens the gateway to the rapid business expansion curtailed by the J&J/Lifescan legal assaults and their campaign of threat and intimidation. During the Genstrip legal hiatus from the market, the company has been intensely preparing for the product re-launch. It now is engaged in conversations with multiple national retailers to re-embrace the functional and financial superiority of GenStrip that they found so compelling in 2013.

Mr. Berman continued, "We are energized and reborn. Wasted years, lost opportunity and unnecessary expense are now behind us. We have won so conclusively that the Federal Circuit Court took the uncommon step of awarding us court costs in their Rule 36 decision. That award punctuated their decision and emphasized their conviction in the ruling. We would like to thank all of our shareholders who have supported our efforts and fought the battle with us. We are fully committed to shortly rewarding their patience, investment and encouragement."

The company has also packed the last several years with the planning and development of a suite of new products that it will begin releasing in 2016. Those additions to the family of diagnostic testing products and devices include:

  • GenUltimate test strip targeted for sale to GPOs, major chain pharmacies, private label sales and mega-distributors.
  • GenSure test strip, a product for international sales to the developing world markets and which will initially feature a test strip and shortly followed by the release of a test meter.
  • The Discretion product line of glucose meter systems empowered by Internet radio devices, designed for remote glucose monitoring of diabetes inflicted school-aged, children

Mr. Berman concluded, "Here we are once again after 3+ years; poised to distribute to the millions of diabetic patients a superior and significantly less expensive test strip that have been denied due to the legal and business harassment of J&J/Lifescan. This time we will not be deterred. Rapid growth will be fulfilled and supported by our contract domestic manufacturer and our newly engaged supplemental international manufacturer.

Forward-Looking Statements: This release contains the Company's forward - looking statements which are based on management's current expectations and assumptions as of February 9, 2016, regarding the Company's business and performance, its prospects, current factors, the economy and other future conditions and forecasts of future events, circumstances and results.

Decision Diagnostics Corp. Keith Berman (805) 446-2973 info@decisiondiagnostics.com www.decisiondiagnostics.com www.pharmatechdirect.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge Sets $0.68 Dividend as 2026 Payouts Rise

Updated Category News Views 128

A community bank raising its cash return is not fireworks, but it gets my attention faster than another glossy growth slogan. Lake Ridge Bancorp has declared a fourth-quarter 2026 dividend of $0.68 per share, payable December 16 to shareholders of record on November 30. That is a plain, useful announcement from OTCQX:LRBI, and plain is often underrated when you are...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
LNG’s Coming Glut Could Gut Global Trading Profits

Updated Category News Views 55

A five-year LNG surplus is the sort of forecast that makes people nod politely today and panic much too late. Bain & Company is putting a hard edge on that risk: the global trading profit pool could slide from an estimated $20 billion in 2026 to roughly $5.5 billion a year during a 2030–34 glut, then potentially tip below zero once cancellation costs bite. That is not a...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 7

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
Full Truck Alliance Profits Surge as Revenue Slows

Updated Category News Views 38

A freight platform just delivered the kind of earnings math that makes investors sit up: sales barely jogged, while profit took off running. Full Truck Alliance’s third-quarter report is plainly strong on the surface, with net income up 49.0% year over year to RMB1.37 billion. Still, this is not a clean, uncomplicated growth story. The quality of the margin jump...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 172

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Subaru's 650-Car Anniversary Bet Is Delightfully Small

Updated Category News Views 112

Gold brake calipers may sound like a fussy correction, yet that little detail tells you exactly who Subaru is trying to please. The company has revised its announcement for the 2027 WRX tS GD25 and BRZ tS ZC15, clarifying the anniversary-model names and changing the WRX description from red-painted to gold-painted Brembo calipers. Nobody should confuse a corrected paint...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 42

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading
ROBOTERA Puts Humanoid Robots Into Logistics Night Work

Updated Category News Views 36

Midnight warehouse work is where a humanoid robot has to quit posing and earn its keep. ROBOTERA arrived at the 2026 APEC CEO Summit with a useful answer to the usual shiny-robot nonsense: it says its machines are already working in logistics centers, handling parcel induction and taking on repetitive, physically demanding shifts that people understandably do not line up...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Gene Therapy Presentation from MeiraGTx at Neuroscience Event

Updated Category News Views 256

MeiraGTx Unveils Promising Research on MC4R Genetic Deficiency MeiraGTx Holdings plc, a pioneering clinical-stage genetic medicine company, has recently made headlines by announcing its participation in a significant neuroscience event. This presentation highlights advancements in treating severe pediatric obesity resulting from MC4R genetic deficiency. The poster...

Continue Reading
Navigating Legal Rights for Shareholders of Flywire Corporation

Updated Category News Views 149

Understanding the Class Action Lawsuit for Flywire Corporation Investors Investors holding shares of Flywire Corporation, referred to as the "Company," should be aware of an ongoing class action lawsuit concerning allegations of securities fraud. The lawsuit aims to ensure that those adversely affected by the Company's actions between specified dates can pursue their...

Continue Reading
LOGISTEC Launches Enhanced Cargo Handling at Baltimore Terminal

Updated Category News Views 235

LOGISTEC Enhances Cargo Handling at Baltimore Terminal LOGISTEC, a prominent North American provider specializing in marine and logistics services, is announcing a significant enhancement to its cargo handling capabilities at its terminal in Baltimore. This advancement comes as LOGISTEC, formerly known as BalTerm, aims to integrate its operations under a unified branding...

Continue Reading
Daversa Partners: Celebrating Recognition as a Top Employer

Updated Category News Views 306

Daversa Partners Recognized as One of the Best Employers Daversa Partners is proud to announce that its Miami office has achieved recognition as one of South Florida’s Best Places to Work for 2025. This significant honor highlights the firm’s unwavering commitment to fostering a workplace culture that champions teamwork and innovation. A Culture of Teamwork and...

Continue Reading
Weaker Jobs Data Sparks Dollar Decline, Rate Cut Hopes

Updated Category Economy Views 648

U.S. Dollar Hits Four-Month Low Amid Weak Jobs Report Friday brought a four-month low in the value of the U.S. dollar. This came after a rather dismal July job report. Employers created just 114,000 new positions according to the report. This far less than the anticipated rise of 175,000. Rising from 4.1%, the unemployment rate also hit 4.3%. These numbers begged...

Continue Reading